Prosecution Insights
Prosecution Insights
3 pending office actions • 0 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Biograil Aps operates in the Medical Devices & Mechanical Engineering technology area with 4 pending office actions. All 4 actions are concentrated within 1 distinct art unit, indicating a very specific technical focus for the company's current filings. The presence of 4 pending office actions shows a significant level of activity within this single specialized area of mechanical engineering.
The company's prosecution involves 4 distinct examiners. VOKES, KATHLEEN PAIGE is the busiest examiner for Biograil Aps, currently managing 1 pending office action. The use of 4 distinct examiners for 4 pending office actions within a single art unit suggests that while the technology is focused, the company is engaging with multiple perspectives within that specialized group. This can provide a broader range of examiner feedback on the company's core technology.
For practitioners, the concentration in 1 distinct art unit simplifies the technical landscape, but the involvement of 4 distinct examiners requires managing four different prosecution styles. VOKES, KATHLEEN PAIGE and the other three examiners each provide an independent review of the company's applications. This structure ensures that the company's medical device innovations are thoroughly vetted by multiple individuals within the same technical department.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VOKES, KATHLEEN PAIGE | 1 | 55.1% | +25.9% |
| WHITROCK, ZACHARIAH KIRBY | 1 | 100.0% | +0.0% |
| GOLOVAN, MARK | 1 | 100.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18699199 | DRUG DELIVERY DEVICE WITH OFFSET ACTUATOR MECHANISM | WHITROCK, ZACHARIAH KIRBY | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18728044 | DRUG DELIVERY DEVICE WITH DETACHMENT CAPABILITIES | VOKES, KATHLEEN PAIGE | — |
| 18696276 | DRUG DELIVERY DEVICE WITH CAPSULE LOCK | GOLOVAN, MARK | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18728044 | DRUG DELIVERY DEVICE WITH DETACHMENT CAPABILITIES | VOKES, KATHLEEN PAIGE | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18728044 | DRUG DELIVERY DEVICE WITH DETACHMENT CAPABILITIES | VOKES, KATHLEEN PAIGE | — | §102§103 | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18699199 | DRUG DELIVERY DEVICE WITH OFFSET ACTUATOR MECHANISM | WHITROCK, ZACHARIAH KIRBY | — | §103 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18696276 | DRUG DELIVERY DEVICE WITH CAPSULE LOCK | GOLOVAN, MARK | — | §102§103 | Non-Final OA | — | Pending | Mar 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial